In a recent study by Tanimoto and colleagues, neffy produced pharmacodynamic results that were comparable with or higher than autoinjectors and manual injection, including more efficient increases in ...
A committee of the Food and Drug Administration's outside advisers voted Thursday in favor of an epinephrine nasal spray product, clearing a key hurdle for what could soon be the first needle-free ...
The designation is supported by data from Part 1 of the EPIPHAST study, which compared the pharmacokinetics and pharmacodynamics of AQST-109 to intramuscular epinephrine in healthy adults. The Food ...
A timely injection of epinephrine can save the life of a person experiencing an allergic reaction. But what if the syringe is jammed? Now, a U.S. company is recalling its version of the critical ...
The Food and Drug Administration approved the first needle-free alternative to the EpiPen on Friday, a single-use epinephrine nasal spray for the emergency treatment of allergic reactions, including ...
The US Food and Drug Administration on Tuesday did not approve a needle-free epinephrine for treatment of severe allergic reactions, a move that drugmaker ARS Pharmaceuticals called surprising.
The Food and Drug Administration has declined to approve an alternative to epinephrine autoinjectors such as EpiPens, telling the maker of a nasal spray that more study is required. ARS Pharma, maker ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback